title: Nutritional factors in the prevention and management of coronary artery disease and heart failure.
abstract: Nutritional factors such as magnesium, folic acid, vitamins B12 and B6, L-arginine, and polyunsaturated fatty acids (PUFAs) appear to be significantly beneficial for patients with coronary artery disease (CAD), and in the prevention and arresting the progression of HF and cardiac arrhythmias. Additionally, ingestion of adequate amounts of protein and maintaining normal concentrations of plasma albumin seem to be essential for these patients. These nutrients closely interact with the metabolism of L-arginine-nitric oxide (NO) system, essential fatty acids, and eicosanoids such that beneficial products such as NO, prostaglandin E1, prostacyclin, prostaglandin I3, lipoxins, resolvins, and protectins are generated and synthesis of proinflammatory cytokines is suppressed that results in platelet anti-aggregation, vasodilation, angiogenesis, and prevention of CAD, cardiac arrhythmias, and stabilization of HF. This implies that individuals at high risk for CAD, cardiac arrhythmias, and HF and those who have these diseases need to be screened for plasma levels of magnesium, folic acid, vitamins B12 and B6, L-arginine, NO, various PUFAs, lipoxin A4, resolvins, protectins, asymmetrical dimethylarginine (an endogenous inhibitor of NO), albumin, and various eicosanoids and cytokines and correct their abnormalities to restore normal physiology.
authors.affiliation: UND Life Sciences, Federal Way, WA, USA and Department of Medicine and BioScience Research Centre, Gayatri Vidya Parishad Hospital, Campus of GVP College of Engineering, Visakhapatnam, India. Electronic address: undurti@hotmail.com.
authors.forename: Undurti N
authors.initials: UN
authors.lastname: Das
mesh_terms: D000527:Alprostadil / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001120:Arginine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D018957:CD59 Antigens / Q000378:metabolism; D003324:Coronary Artery Disease / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D011464:Epoprostenol / Q000031:analogs & derivatives / Q000378:metabolism; D005228:Fatty Acids, Essential / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D005260:Female; D005492:Folic Acid / Q000494:pharmacology; D006333:Heart Failure / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D044045:Lipoxins / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism; D009752:Nutritional Status; D012709:Serum Albumin / Q000378:metabolism; D014664:Vasodilation / Q000187:drug effects; D014805:Vitamin B 12 / Q000494:pharmacology; D025101:Vitamin B 6 / Q000494:pharmacology
chemical_list: D000893:Anti-Inflammatory Agents; D018957:CD59 Antigens; D005228:Fatty Acids, Essential; D005231:Fatty Acids, Unsaturated; D044045:Lipoxins; D012709:Serum Albumin; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; C034240:prostaglandin I3; D025101:Vitamin B 6; D005492:Folic Acid; D001120:Arginine; D011464:Epoprostenol; D000527:Alprostadil; D008274:Magnesium; D014805:Vitamin B 12
keywords: Arrhythmias; Asymmetrical dimethylarginine; Atherosclerosis; Coronary artery disease; Cytokines; Eicosanoids; Heart failure; Lipoxins; Magnesium; Nitric oxide; Nutrients; Polyunsaturated fatty acids; Protectins; Pyridoxine; Resolvins; Vitamins; l-arginine